Prevalence and predictors of obesity among individuals with positive hepatitis C antibody in a tertiary referral clinic

Journal of Hepatology

Volumn 49, Issue 5, 2008, Pages 711-717

  Chen, Wendong ^a   Wong, Terence ^b   Tomlinson, George ^b   Krahn, Murray ^a,b   Heathcote, E Jenny ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Body mass index; Hepatitis C; Obesity; Prevalence

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TERTIARY HEALTH CARE; VIRUS TRANSMISSION;

ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; OBESITY; ONTARIO; RNA, VIRAL; YOUNG ADULT;

EID: 53249090462     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.05.013     Document Type: Article

References (29)

1. Weekly Epidemiological Record. No. 49, 10 December 1999, WHO.
2. Czaja A.J., Carpenter H.A., Santrach P.J., and Moore S.B. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 29 (1998) 198-206
3. Monto A., Alonzo J., Watson J.J., Grunfeld C., and Wright T.L. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology 36 (2002) 729-736
4. Wanless I.R., and Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12 (1990) 1106-1110
5. Ratziu V., Giral P., Charlotte F., Bruckert E., Thibault V., Theodorou I., et al. Liver fibrosis in overweight patients. Gastroenterology 118 (2000) 1117-1123
6. http://www.statcan.ca/english/research/82-620-MIE/2005001/tables.htm.
7. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
8. Rosenbaum P.R. Discussing hidden bias in observational studies. Ann Intern Med 115 (1991) 901-905
9. Rosenbaum P.R., and Rubin D.B. Reducing bias in observational studies using sub classification on the propensity score. J Am Stat Assoc 79 (1984) 516-524
10. Rosenbaum P.R., and Rubin D.B. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 39 (1985) 33-38
11. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Available from: Http://www2.sas.com/proceedings/sugi26/p214-26.pdf.
12. Remis R, Hogg R, Krahn MD. Estimating the number of blood transfusion recipients infected by hepatitis C virus in Canada, 1960-85 and 1990-92. Report to Health Canada, June 1998.
13. Canadian Addiction Survey (CAS). Available from: http://www.ccsa.ca/NR/rdonlyres/B2C820A2-C987-4F08-8605-2BE999FE4DFC/0/ccsa0048042004.pdf.
14. Health Canada. Tobacco control programme, Health Canada supplementary tables, CTUMS annual 2002. Available from: http://www.hcsc.gc.ca/hecssesc/tobacco/research/ctums/2002/2002-supptables.eng.pdf.
15. 2001 Census of Canada. Available from: Http://www12.statcan.ca/english/census01/home/index.cfm.
16. Reddy J.K., and Rao M.S. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 290 (2006) G852-G858
17. Asselah T., Rubbia-Brandt L., Marcellin P., and Negro F. Steatosis in chronic hepatitis C: why does it really matter?. Gut 55 (2006) 123-130
18. Lo Iacono O., Venezia G., Petta S., Mineo C., De Lisi S., Di Marco V., et al. The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Aliment Pharmacol Ther 25 (2007) 1181-1191
19. Hassoun Z., Willems B., Deslauriers J., Nguyen B.N., and Huet P.M. Assessment of fatigue in patients with chronic hepatitis C using the Fatigue Impact Scale. Dig Dis Sci 47 (2002) 2674-2681
20. Schmaling K.B., Fiedelak J.I., Bader J., and Buchwald D. A longitudinal study of physical activity and body mass index among persons with unexplained chronic fatigue. J Psychosom Res 58 (2005) 375-381
21. Golden J., O'Dwyer A.M., and Conroy R.M. Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Gen Hosp Psychiatry 27 (2005) 431-438
22. Angelopoulos N., Goula A., and Tolis G. Current knowledge in the neurophysiologic modulation of obesity. Metabolism 54 (2005) 1202-1217
23. Romero-Gomez M., Castellano-Megias V.M., Grande L., Irles J.A., Cruz M., Nogales M.C., et al. Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Am J Gastroenterol 98 (2003) 1135-1141
24. Piche T., Vandenbos F., Abakar-Mahamat A., Vanbiervliet G., Barjoan E.M., Calle G., et al. The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C. J Viral Hepat 11 (2004) 91-96
25. Basu A., Meyer K., Lai K.K., Saito K., Di Bisceglie A.M., Grosso L.E., et al. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology 349 (2006) 347-358
26. Masaki N., Fukushima S., and Hayashi S. Lower th-1/th-2 ratio before interferon therapy may favor long-term virological responses in patients with chronic hepatitis C. Dig Dis Sci 47 (2002) 2163-2169
27. Muller M.J., Willmann O., Rieger A., Fenk A., Selberg O., Lautz H.U., et al. Mechanism of insulin resistance associated with liver cirrhosis. Gastroenterology 102 (1992) 2033-2041
28. Lam T.K.T., Gutierrez R., Pocai A., Bhanot S., Tso P., Schwartz G.J., et al. Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat Med 13 (2007) 171-180
29. Shintani Y., Fujie H., Miyoshi H., Tsutsumi T., Tsukamoto K., Kimura S., et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126 (2004) 840-848